Douglas CDMO
2 Te Pai Place, Henderson
Auckland, New Zealand 0610
T: +64 9 835 0660
E: enquiry@douglascdmo.com
W: douglascdmo.com

 

Company Description
Douglas CDMO, based in New Zealand, has a history dating back to 1967. We offer end-to-end integrated drug development services, specializing in high-potency small molecule softgels, liquids, semi-solids, new chemical entities (NCEs), and branded generics.

Our capabilities extend to manufacturing prescription drugs across key therapeutic areas, including oncology, dermatology, the central nervous system, and immunity. Working with clients across the globe, we pride ourselves on delivering superior quality and excellent service, ensuring our partners achieve successful, timely outcomes.

Our strategic location in Auckland, New Zealand offers our global customers with tax incentives and the ability to start first in human trials quicker than many other jurisdictions due to a streamlined regulatory process.

Services
Our CDMO services offer comprehensive support at every stage of the product lifecycle, from pre-formulation to commercialization. In addition to developing and manufacturing, we can also undertake technology transfers of pre-established projects into our facilities.

We have the capability and procedures to manage your light-sensitive retinoids, hormones, cytotoxics, and immunosuppressants.

Product Capabilities
Softgel capsules
Liquids – including solutions, emulsions and suspensions
Sem-solids – including creams, gels and ointments
Hard gel capsules
Suppositories
Tablets

Packaging Capabilities
Blisters
Liquid bottles/sprays
ALU-ALU blisters
Bottles

World-Class Expertise in Softgels, Liquids & Semi-Solids
Douglas CDMO brings extensive expertise in the development and manufacturing of softgel capsules and their inner fill, having developed approximately one-third of the pharmaceutical softgels available in the U.S. market. With a high success rate in developing complex softgels and securing approvals, we are committed to delivering products that meet the highest standards of safety and efficacy, leveraging our technical expertise and advanced technological capabilities.

If you haven’t considered a soft gelatin capsule as your next dosage form, here are some of the key advantages:

• Enhanced absorption rate, and overall bioavailability of the drug to ensure the lowest effective dose is used to achieve its full therapeutic effect.
• Addressing solubility issues.
• Protection of ingredients from exposure to light, air and moisture.
• Easier to swallow than hardshell capsules and tablets.
• A consistent and precise dose of the active ingredient.
• Enhanced shelf life.

The complex nature of softgel manufacturing, which requires specialized equipment and custom formulations, creates significant challenges for generic production. This complexity helps maintain product quality and efficacy, protecting your investment.

Why choose Douglas CDMO for your contract development and manufacturing?
At Douglas CDMO, we deliver a personalized, tailored service designed to meet the unique needs of each customer. We prioritize open communication and close collaboration, ensuring we fully understand and address your specific requirements. We remain agile, quickly adapting to meet the evolving needs of our customers.

Customers trust Douglas CDMO to maintain the highest quality standards, honor our commitments, and tackle challenges with resilience and integrity. Quality is at the heart of everything we do — from the initial stages of development to commercial manufacturing and supply.

Articles you may be interested in:

Softgel technology: A game-changer for oncology treatment?

Smart softgels: driving innovation in pharma

The case for softgels: Addressing stability, shelf-life, and bioavailability issues in pharmaceutical formulation